Clinical Trial Update: Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS. [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial evaluated a sub-therapeutic GnRH antagonist to rectify LH pulsatility in lean women with polycystic ovary syndrome and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• GnRH antagonist (sub-therapeutic)

Snippet

Sponsor: University Hospital, Lille | Conditions: Polycystic Ovary Syndrome | EARLY_Phase 1 | Status: COMPLETED